Interest Income Expense - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Interest Income Expense Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Interest Income Expense
-ÂŁ638m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
0%
A
AstraZeneca PLC
NASDAQ:AZN
Interest Income Expense
-$1.3B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
-9%
Indivior PLC
LSE:INDV
Interest Income Expense
$5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Interest Income Expense
-$79m
CAGR 3-Years
-17%
CAGR 5-Years
-18%
CAGR 10-Years
-9%
Allergy Therapeutics PLC
LSE:AGY
Interest Income Expense
-ÂŁ4.9m
CAGR 3-Years
-152%
CAGR 5-Years
-100%
CAGR 10-Years
-44%
Dechra Pharmaceuticals PLC
LSE:DPH
Interest Income Expense
-ÂŁ21m
CAGR 3-Years
-34%
CAGR 5-Years
-30%
CAGR 10-Years
-14%

See Also

What is GlaxoSmithKline PLC's Interest Income Expense?
Interest Income Expense
-638m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Interest Income Expense amounts to -638m GBP.

What is GlaxoSmithKline PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
0%

Over the last year, the Interest Income Expense growth was 15%. The average annual Interest Income Expense growth rates for GlaxoSmithKline PLC have been 6% over the past three years , 3% over the past five years .

Back to Top